Kazia Receives FDA Orphan Designation for GDC-0084
- Written by LATEST ASIANET NEWS RELEASES
- Category: Asia Net
SYDNEY, Feb. 23, 2018 /PRNewswire-AsiaNet/-- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Kazia's invest......